학술논문
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma.
Document Type
Article
Author
Zinzani, Pier Luigi; Mayer, Jiří; Flowers, Christopher R.; Bijou, Fontanet; De Oliveira, Ana C.; Song, Yuqin; Zhang, Qingyuan; Merli, Michele; Bouabdallah, Krimo; Ganly, Peter; Zhang, Huilai; Johnson, Roderick; Martín García-Sancho, Alejandro; Provencio Pulla, Mariano; Trněný, Marek; Yuen, Sam; Tilly, Herve; Kingsley, Edwin; Tumyan, Gayane; Assouline, Sarit E.
Source
Journal of Clinical Oncology; 11/20/2023, Vol. 41 Issue 2, p5107-5117, 13p
Subject
Language
ISSN
0732183X